VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
47 hedge funds and large institutions have $28M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
7% more funds holding
Funds holding: 44 → 47 (+3)
Holders
47
Holding in Top 10
5
Calls
$88K
Puts
$31K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.25M | |
| 3 | +$1.21M | |
| 4 |
BlackRock
New York
|
+$468K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$332K |
Top Sellers
| 1 | -$588K | |
| 2 | -$151K | |
| 3 | -$146K | |
| 4 |
BL
Bleichroeder LP
New York
|
-$99K |
| 5 |
Millennium Management
New York
|
-$65K |